Preliminary results from a randomized, phase II trial have shown that the transdermal estrogen patch Fem7 ® (Merck KGaA, Darmstadt, Germany) can suppress testosterone to castrate levels in men ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback